These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 20803608

  • 1. Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ.
    Wai ES, Lesperance ML, Alexander CS, Truong PT, Culp M, Moccia P, Lindquist JF, Olivotto IA.
    Cancer; 2011 Jan 01; 117(1):54-62. PubMed ID: 20803608
    [Abstract] [Full Text] [Related]

  • 2. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.
    Jiveliouk I, Corn B, Inbar M, Merimsky O.
    Oncology; 2009 Jan 01; 76(1):30-5. PubMed ID: 19033713
    [Abstract] [Full Text] [Related]

  • 3. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194.
    Motwani SB, Goyal S, Moran MS, Chhabra A, Haffty BG.
    Cancer; 2011 Mar 15; 117(6):1156-62. PubMed ID: 21381008
    [Abstract] [Full Text] [Related]

  • 4. Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins?
    Chan LW, Rabban J, Hwang ES, Bevan A, Alvarado M, Ewing C, Esserman L, Fowble B.
    Int J Radiat Oncol Biol Phys; 2011 May 01; 80(1):25-30. PubMed ID: 20646871
    [Abstract] [Full Text] [Related]

  • 5. Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up.
    Jobsen JJ, van der Palen J, Ong F.
    Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):115-22. PubMed ID: 18234450
    [Abstract] [Full Text] [Related]

  • 6. Management of ductal carcinoma in situ of the breast.
    Carty NJ, Carter C, Royle GT, Johnson CD.
    Ann R Coll Surg Engl; 1995 May 01; 77(3):163-7. PubMed ID: 7598411
    [Abstract] [Full Text] [Related]

  • 7. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
    Donker M, Litière S, Werutsky G, Julien JP, Fentiman IS, Agresti R, Rouanet P, de Lara CT, Bartelink H, Duez N, Rutgers EJ, Bijker N.
    J Clin Oncol; 2013 Nov 10; 31(32):4054-9. PubMed ID: 24043739
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
    Yerushalmi R, Sulkes A, Mishaeli M, Neumann A, Dinerman M, Sulkes J, Rizel S, Yarom N, Gutman H, Fenig E.
    Neoplasma; 2006 Nov 10; 53(6):507-10. PubMed ID: 17167720
    [Abstract] [Full Text] [Related]

  • 13. [Target volume and indications of radiotherapy in breast carcinoma].
    Greiner RH.
    Praxis (Bern 1994); 1998 Apr 22; 87(17):595-601. PubMed ID: 9623327
    [Abstract] [Full Text] [Related]

  • 14. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
    Dunne C, Burke JP, Morrow M, Kell MR.
    J Clin Oncol; 2009 Apr 01; 27(10):1615-20. PubMed ID: 19255332
    [Abstract] [Full Text] [Related]

  • 15. [Radiotherapy for breast cancer: which strategy in 2012?].
    Cutuli B.
    Cancer Radiother; 2012 Sep 01; 16(5-6):493-502. PubMed ID: 22925489
    [Abstract] [Full Text] [Related]

  • 16. [Local recurrence of ductal in situ carcinoma of the breast].
    Dunst J.
    Strahlenther Onkol; 1999 Jul 01; 175(7):348-9. PubMed ID: 10432998
    [No Abstract] [Full Text] [Related]

  • 17. Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer.
    Gold HT, Do HT, Dick AW.
    Cancer; 2008 Dec 01; 113(11):3108-15. PubMed ID: 18932243
    [Abstract] [Full Text] [Related]

  • 18. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
    Harms W, Krempien R, Hensley FW, Berns C, Fritz P, Wannenmacher M.
    Strahlenther Onkol; 2002 Nov 01; 178(11):607-14. PubMed ID: 12426671
    [Abstract] [Full Text] [Related]

  • 19. Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.
    Hamilton SN, Nichol A, Wai E, Gondara L, Velásquez García HA, Speers C, Diocee R, Truong P.
    Int J Radiat Oncol Biol Phys; 2019 Feb 01; 103(2):381-388. PubMed ID: 30253237
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.